Bain Capital Life Sciences
Bain Capital investment business specialising in biotechnology, medicines, medical devices and diagnostics.
Bain Capital Life Sciences backs medical businesses across development stages, drawing on specialist healthcare expertise and the wider Bain Capital organisation.
Last refreshed: 22 October 2026 · Appears in 1 active topic
Timeline for Bain Capital Life Sciences
Co-led the $310m Series C
UK Startups and Innovation: Oxford's OMass raises $310m on foreign leadsBackground
[Bain Capital Life Sciences](https://www.baincapitallifesciences.com/) is the life-sciences investment business within Bain Capital. It invests internationally in companies developing medicines, medical devices, diagnostics and research tools. Its team combines experience in the healthcare industry with public and private investing, drawing on the wider Bain Capital organisation when working with portfolio companies.
The business funds companies at different points in their development. Its [approach](https://www.baincapitallifesciences.com/approach) includes growth capital, investment around important business or clinical milestones, and the creation of new companies. It also participates in larger private-equity investments with other Bain Capital Teams. The investment remit covers both the development of treatments and the equipment and services used in medical research.
What is Bain Capital Life Sciences?
What did Bain Capital Life Sciences fund at OMass?
What will the OMass financing support?
Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Updated 22 October 2026. Editorial standards.